The Sidney Kimmel Cancer Center would like to congratulate Wm. Kevin Kelly, D.O., Professor of Medical Oncology and Director of the Division of Solid Tumor Oncology, on his new appointment as the Leader of the Biology of Prostate Cancer Program. Dr. Kelly has been a considerable asset to the cancer center and Jefferson as a whole since his recruitment in 2010, and he brings substantial translational and clinical expertise to this role.
In addition to his 25 years of experience as a clinician, Dr. Kelly is a nationally recognized translational researcher, known for his work on urological malignancies and his expertise in drug design and development. Kelly’s research linking elevated prostate-specific antigen levels to prostate cancer treatment outcomes remains a foundation for drug development in patients with advanced prostate cancer today.
Prior to joining the Jefferson faculty, Dr. Kelly directed the Clinical Research Management Office at the Yale Comprehensive Cancer Center and co-directed prostate and urological oncology program at Yale University. He spent the previous 15 years on the faculty at Memorial-Sloan Kettering Cancer Center in the Genitourinary Oncology Division.